Gilead Sciences, the drug giant behind the blockbuster HIV prevention pill Truvada, won FDA approval on Thursday to market Descovy a medication already used by those who have HIV as its next-generation prevention drug.
The final approval follows an August vo…
Read More
FDA approves Gilead’s next-generation HIV PrEP pill, Descovy – NBC News
